BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20020423)

  • 1. Specification of covariance structure in longitudinal data analysis for randomized clinical trials.
    Lu K; Mehrotra DV
    Stat Med; 2010 Feb; 29(4):474-88. PubMed ID: 20020423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients.
    AIDS; 2000 Mar; 14(4):367-74. PubMed ID: 10770538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials.
    Jones AP; Riley RD; Williamson PR; Whitehead A
    Clin Trials; 2009 Feb; 6(1):16-27. PubMed ID: 19254930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simple adjustments for randomized trials with nonrandomly missing or censored outcomes arising from informative covariates.
    Baker SG; Fitzmaurice GM; Freedman LS; Kramer BS
    Biostatistics; 2006 Jan; 7(1):29-40. PubMed ID: 15923407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smooth bootstrap methods for analysis of longitudinal data.
    Li Y; Wang YG
    Stat Med; 2008 Mar; 27(7):937-53. PubMed ID: 17701950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonparametric estimation of covariance structure in longitudinal data.
    Diggle PJ; Verbyla AP
    Biometrics; 1998 Jun; 54(2):401-15. PubMed ID: 9629635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The analysis of very small samples of repeated measurements I: an adjusted sandwich estimator.
    Skene SS; Kenward MG
    Stat Med; 2010 Nov; 29(27):2825-37. PubMed ID: 20839367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A bias-corrected covariance estimate for improved inference with quadratic inference functions.
    Westgate PM
    Stat Med; 2012 Dec; 31(29):4003-22. PubMed ID: 22807168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of bias-corrected covariance estimators for MMRM analysis in longitudinal data with dropouts.
    Gosho M; Hirakawa A; Noma H; Maruo K; Sato Y
    Stat Methods Med Res; 2017 Oct; 26(5):2389-2406. PubMed ID: 26265765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intention-to-treat analyses for incomplete repeated measures data.
    Hogan JW; Laird NM
    Biometrics; 1996 Sep; 52(3):1002-17. PubMed ID: 8805765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of two methods for the estimation of precision with incomplete longitudinal data, jointly modelled with a time-to-event outcome.
    Touloumi G; Babiker AG; Kenward MG; Pocock SJ; Darbyshire JH
    Stat Med; 2003 Oct; 22(20):3161-75. PubMed ID: 14518021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Durable HIV-1 suppression with indinavir after failing lamivudine-containing double nucleoside therapy: a randomized controlled trial.
    Foudraine NA; Jurriaans S; Weverling GJ; Burger DM; Hoetelmans RM; Roos MT; Maas J; Miedema F; Reiss P; Portegies P; de Wolf F; Lange JM
    Antivir Ther; 2001 Mar; 6(1):55-62. PubMed ID: 11417762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy.
    Hirsch M; Steigbigel R; Staszewski S; Mellors J; Scerpella E; Hirschel B; Lange J; Squires K; Rawlins S; Meibohm A; Leavitt R
    J Infect Dis; 1999 Sep; 180(3):659-65. PubMed ID: 10438352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACTG 320 trial halted as three-drug arm proves superior.
    AIDS Patient Care STDS; 1997 Jun; 11(3):194. PubMed ID: 11361796
    [No Abstract]   [Full Text] [Related]  

  • 15. Robust analysis of biomarker data with informative missingness using a two-stage hypothesis test in an HIV treatment interruption trial: AIEDRP AIN503/ACTG A5217.
    Messer K; Vaida F; Hogan C
    Contemp Clin Trials; 2006 Dec; 27(6):506-17. PubMed ID: 16962381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Undetectable HIV levels after triple therapy with indinavir.
    AIDS Patient Care STDS; 1997 Jun; 11(3):193-4. PubMed ID: 11361795
    [No Abstract]   [Full Text] [Related]  

  • 17. Simultaneous inference for longitudinal data with detection limits and covariates measured with errors, with application to AIDS studies.
    Wu L
    Stat Med; 2004 Jun; 23(11):1715-31. PubMed ID: 15160404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of indinavir on the quality of life in patients with advanced HIV infection treated with zidovudine and lamivudine.
    Coplan PM; Cook JR; Carides GW; Heyse JF; Wu AW; Hammer SM; Nguyen BY; Meibohm AR; DiNubile MJ;
    Clin Infect Dis; 2004 Aug; 39(3):426-33. PubMed ID: 15307012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling progression of CD4-lymphocyte count and its relationship to survival time.
    De Gruttola V; Tu XM
    Biometrics; 1994 Dec; 50(4):1003-14. PubMed ID: 7786983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A semiparametric Bayesian approach to the random effects model.
    Kleinman KP; Ibrahim JG
    Biometrics; 1998 Sep; 54(3):921-38. PubMed ID: 9750242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.